Articles tagged with Chronic Obstructive Pulmonary Disease
New research shows individual COPD exacerbations increase repeat likelihood, driving disease progression. Patients may be 'brittle' during a subsequent eight-week period, requiring close monitoring and follow-up to prevent further exacerbations.
New research finds that long-term use of inhaled corticosteroid drugs increases the risk of pneumonia in patients with Chronic Obstructive Pulmonary Disease (COPD). Analysis of 18 randomized clinical trials showed a significant association between corticosteroid inhaler use and pneumonia, with nearly one in every 47 patients developing...
A new study from the University of Cincinnati finds that cigarette smoke can activate specific immune system receptors, leading to worsening of chronic obstructive pulmonary disorder (COPD) symptoms. The research identified a key cellular receptor, NKG2D, involved in this process.
Researchers found that activating Nrf2 can prevent emphysema in mice by reducing oxidative stress and improving lung function. The study suggests targeting Nrf2 could be a novel strategy for preventing chronic obstructive pulmonary disease (COPD).
A study by Drs. François Maltais and Jean Bourbeau found that home-based pulmonary rehabilitation is as effective as hospital-based treatment in improving symptoms and quality of life for COPD patients. The program, which involves aerobic exercises, can be performed alone and has the potential to reduce healthcare costs.
A new study published in Annals of Internal Medicine finds that colonoscopy significantly reduces deaths from colorectal cancer due to left-sided cancers. However, the risk reduction is negligible for right-sided cancer. The study suggests that physicians should advise patients of the limitations of colonoscopy.
The study aims to develop an understanding of COPD pathogenesis and yield tools for stratifying and treating patients based on molecular processes. The research will help identify the molecular processes that give rise to disease-specific symptoms in individual patients.
Researchers found that inhaled corticosteroid drugs increase the risk of pneumonia by a full third in people with chronic obstructive pulmonary disease (COPD). The study suggests that the treatment may be more harmful and pose a greater risk to some individuals, particularly those with weakened immune systems.
A review of 11 randomized trials found no benefit in survival from inhaled corticosteroid therapy for stable COPD. However, the use of ICS was associated with a higher incidence of pneumonia in patients with COPD.
A year-long study found that long-term use of a macrolide antibiotic reduced COPD exacerbations by 35% in patients with moderate to severe disease. The treatment also decreased the severity and duration of exacerbations, but its benefits are offset by concerns about growing antibiotic resistance.
Researchers have shown that HRV hijacks many of your genes, leading to an overblown immune response. The study identifies novel candidate genes that could be targeted for drug development to treat colds and exacerbations of asthma and COPD.
Research suggests depression and anxiety can cause increased hospitalizations and exacerbations in COPD patients, with depressed individuals experiencing more symptom- and event-based exacerbations and longer hospital stays. Anxiety is also linked to a greater risk of exacerbations and longer hospital stays.
A study finds that eliminating smoking and solid fuel use in China could prevent millions of deaths from chronic diseases. Gradual elimination or moderate-aggressive interventions could avoid 26-31 million COPD deaths and 6.3 million lung cancer deaths by 2033.
A Harvard T.H. Chan School of Public Health study projects that China will experience an estimated 65 million COPD deaths and 18 million lung cancer deaths between 2003 and 2033 if current smoking and biomass fuel use levels continue, highlighting the need for large-scale interventions to reduce disease burden
Researchers found that cardio-selective beta-blockers significantly reduced mortality in both COPD and non-COPD patients within 30 days of surgery. Long-term mortality reductions were also observed among COPD patients on beta-blockers, with a higher risk of death among those not receiving the medication.
Researchers found that long-term use of inhaled anticholinergics for COPD increases the risk of cardiovascular death, heart attacks, or strokes by 58%. Patients with COPD who use these inhalers are at high risk of excess serious cardiovascular events.
A meta-analysis of randomized trials found that inhaled anticholinergic agents significantly increase the risk of heart attack, stroke, and cardiovascular death by 58% and 80% respectively. The study suggests clinicians closely monitor patients with COPD taking these medications for potential long-term cardiovascular risks.
A new study from Northwestern University's Feinberg School of Medicine found that ipratropium increases the risk of heart attack or arrhythmia by 34% compared to albuterol or no treatment. The study suggests that the medication may have a systemic cardiovascular effect, increasing mortality risk in COPD patients.
A study by Johns Hopkins researchers found that NRF2, a master gene regulating antioxidant and pollutant-detoxifying genes, is significantly decreased in smokers with advanced COPD compared to those without. This discovery could lead to new drug therapies targeting the condition.
Research suggests that eating broccoli may help patients with chronic lung disease by reducing oxidative stress and inflammation. The study found decreased levels of NRF2-dependent antioxidants and increased oxidative stress markers in lungs of smokers with COPD.
The Toward a Revolution in COPD Health (TORCH) study found that combined salmeterol and fluticasone propionate reduced the rate of decline in lung function by 39ml/year, compared to 55ml/year in the placebo group.
A randomized, placebo-controlled study found that creatine supplementation had negligible effects on exercise function in patients with chronic obstructive pulmonary disease (COPD). Despite increased muscle creatine levels, the study's results suggest that physical training alone remains essential for improving outcomes.
Research published in BMC Health Services Research found that only a small minority of eligible elderly patients receive recommended treatments for obstructive respiratory diseases. The study revealed significant disparities in care, including low rates of bronchodilator inhaler use and lung function exams.
A randomized controlled trial found carbocisteine significantly reduced yearly exacerbation rates in Chinese patients with COPD by 25% compared to placebo. This mucolytic drug may be a worthwhile treatment for prevention of exacerbations, particularly in developing countries.
Researchers found that carrying alpha-1 antitrypsin deficiency increases lung cancer risk in smokers and nonsmokers, with the genetic disorder explaining up to 12% of lung cancer patients. Individuals who carry the gene should be screened for lung cancer and avoid potential carcinogens.
A new study found that patients with chronic obstructive pulmonary disease (COPD) who receive low-intensity case management experience significant reductions in emergency room visits and hospitalizations. This simple yet effective model also improves quality of life measures.
The study shows that Perforomist Inhalation Solution delivers bronchodilation comparable to DPI delivery and has similar linear kinetics and excreted drug levels. This offers an effective, long-term treatment option for patients with COPD who may have difficulty coordinating other devices.
A clinical trial found that combining nebulized formoterol fumarate with tiotropium significantly improves dyspnea, COPD symptoms, and rescue medication use. The treatment also shows promise in relieving shortness of breath, chest tightness, and nighttime awakenings.
Researchers found that COPD patients who lived longer than two years obtained more positive results from their PR program than those with end-stage COPD. The study suggests that other factors present at end of life may contribute to poorer outcomes in exercise capacity and quality of life.
A study found that combining nebulized formoterol fumarate with tiotropium significantly improved COPD symptoms, including shortness of breath and chest tightness, in patients. The treatment also showed enhanced control of COPD symptoms, with decreased use of albuterol rescue medication.
Researchers found that markers of oxidative stress were positively associated with declines in lung function five years later. The study used data from the CARDIA cohort and found associations between oxidized LDL and lower lung function in both men and women, but particularly in women.
A Canadian study finds that video-conferencing technology improves pulmonary rehabilitation outcomes for rural patients with chronic obstructive pulmonary disease (COPD). The TELEHEALTH program, which uses video and communications technologies to deliver exercise programs under direct supervision, shows similar results to standard in-p...
Researchers at WashU Medicine have identified a new type of immune response linked to severe asthma and COPD, enabling more precise diagnosis and targeted treatment. The study's findings promise to revolutionize the management of chronic inflammatory lung disease by detecting specific biomarkers in the lungs or bloodstream.
Research found that annual flu vaccines reduced acute respiratory illness and exacerbations of COPD by 67% and 50%, respectively. Patients with severe COPD experienced a 75% reduction in respiratory problems.
Researchers found that COPD patients who used a computer game to control their breathing showed significant improvements in exercise duration and reduced exercise-induced hyperinflation. The study suggests that teaching these breathing techniques to daily activities could greatly improve quality of life for patients.
A study finds that insufficient hydration of the airway surfaces leads to pathologies typical of chronic obstructive lung diseases in humans. This could lead to a new therapeutic strategy for treating asthma and COPD by improving mucus clearance through sodium channel blockers.
Bilateral lung transplantation in younger patients with end-stage COPD provides longer survival than single lung transplantation, with median survival times of 6.41 and 4.59 years, respectively. This finding holds true even after adjusting for pre-transplant characteristics.
Researchers found that black patients with COPD were less likely to receive a lung transplant and more likely to die or be removed from the transplant list than white patients. Despite differences in insurance, socioeconomic status, and cardiovascular risk factors, these disparities persisted.
Researchers at Northwestern University found that high CO2 levels impair lung function and increase the risk of edema. The study suggests reducing CO2 levels to improve treatment outcomes for patients with respiratory distress.
Researchers have discovered that cigarette smoke depletes the Sirtuin (SIRT1) gene, which protects against premature aging and inflammation. Testing antioxidant resveratrol may help restore this gene to prevent lung damage and diseases like COPD and lung cancer.
A recent study found that patients with severe COPD who received salmeterol-fluticasone (SFC) therapy had lower mortality rates compared to those treated with tiotropium. Additionally, SFC treatment was associated with better health status and fewer patient withdrawals.
Women are more prone to developing COPD due to exposure to risk factors like cigarette smoke, leading to distinct manifestations of the disease. They also experience different symptoms, diagnoses, and treatment outcomes compared to men.
A new study presented at AARC found that ramelteon did not exacerbate respiratory depressant effects in patients with moderate to severe chronic obstructive pulmonary disease (COPD). The study showed significant increases in total sleep time and sleep efficiency with ramelteon compared to placebo.
Researchers developed a new modified comorbidity index to predict post-liver-transplant survival, considering comorbidities such as coronary disease, diabetes, and COPD. This index predicted survival as well or better than other models using recipient characteristics.
The American College of Physicians has released a new clinical practice guideline on diagnosing and treating stable chronic obstructive pulmonary disease (COPD). The guidelines recommend the use of spirometry in patients with respiratory symptoms, particularly shortness of breath, to diagnose airflow obstruction. For symptomatic patien...
Concomitant use of nebulized formoterol fumarate and tiotropium shows improved bronchodilation in COPD patients, with fewer adverse events. The study demonstrated significant improvements in lung function and clinical outcomes for COPD patients with moderate to severe disease manifestations.
Elderly patients with DVT are less likely to present typical symptoms and receive treatment outpatient. Researchers suggest that these patients represent a high-risk group due to the combination of DVT and COPD.
Two clinical trials demonstrated that Perforomist Inhalation Solution is a safe and effective treatment for moderate-to-severe COPD. The studies found no significant increases in cardiovascular events or adverse effects, making it a welcome addition to the physician's arsenal.
Researchers have discovered that vitamin supplementation can temporarily improve lung function in smokers. In contrast, athletic activity has been shown to strengthen respiratory muscles and enhance lung function. Additionally, light to moderate drinking may also be associated with better lung function, according to a recent study.
Researchers found that patients with COPD commonly receive the same medication prescriptions, regardless of whether they've undergone spirometry testing. Modified Tai Chi exercises may also improve exercise capacities and quality of life in patients with COPD.
A new study shows that 32.1% of patients with asthma or COPD use their dry powder inhalers (DPIs) incorrectly, leading to increased morbidity and mortality. The error rate increases with age and severity of airway obstruction.
A large-scale study in China reveals that COPD prevalence is significantly higher than previously thought, affecting over 8% of the population over 40. The risk factors identified include smoking, particularly among women, and exposure to biomass fuels, highlighting a need for preventative measures and improved diagnosis.
The updated GOLD report provides new standards for diagnosing and managing chronic obstructive pulmonary disease (COPD), emphasizing the importance of proper diagnosis and assessment. The report also highlights the need to understand co-morbidities and implement effective strategies for prevention, treatment, and management.
COPD is a leading cause of morbidity and mortality globally, with smoking being a primary risk factor. The International Burden of Lung Disease (BOLD) Study found that eastern Kentucky had one of the highest rates of COPD in the world.
Researchers found that indoor concentrations of particulate pollution frequently exceeded standards for outdoor air, with high levels recorded in homes of patients with COPD. The study highlights the need for further research into the impact of indoor air quality on adults with COPD.
Researchers found that infants with poor lung function at birth continued to experience reduced lung function up to age 22. The study suggests that early prenatal intervention may be necessary to prevent chronic obstructive pulmonary disease (COPD) in adulthood.
A study published in The Lancet found that exposure to passive smoking increases the risk of developing COPD by 48% among never smokers in China. With over 60% of adults being never smokers, high levels of passive smoking are expected to result in approximately 1.9 million excess deaths from COPD.
A study of 9,425 people in 12 countries found a higher prevalence of stage II or higher COPD than previously estimated. The disease is expected to increase as the global population ages due to risk factors such as tobacco use and occupational exposures.
The Lancet proposes adding chronic systemic inflammatory syndrome to COPD diagnosis to address frequent comorbidities and improve patient care. Patients with COPD often die from non-respiratory disorders such as cardiovascular disease or cancer.
A recent study suggests that ambulatory oxygen therapy is not beneficial for COPD patients without resting hypoxemia, contrary to routine prescribing practices. The researchers found improvements in exercise performance but no benefits in daily life or quality of life.